Dudediligence.

Scilex Holding Company

SCLXNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price

From the filings

Figures

Revenue
$31.6Mlast 12 months
Net income
−$464.6Mlast 12 months
Operating cash flow
−$3.3Mlast 12 months
Cash and equivalents
$566,000at the last balance sheet
Total debt
$80.8Mat the last balance sheet
Shares outstanding
7.0M shareson issue
Every year and quarter →